Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2019-02-05

Clinical Trial Update: Estradiol-mediated Neural Plasticity as Potential Mediator of Neurofeedback Treatment Change for Traumatized Women [NA]

View source ↗

Summary

An update on a clinical trial exploring whether estradiol-related neural plasticity mediates changes in neurofeedback treatment for women with PTSD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRADIOL (Estradiol)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Posttraumatic Stress Disorder (PTSD) | NA | Status: UNKNOWN